miércoles, 18 de diciembre de 2024

Atezolizumab Plus Neoadjuvant Chemotherapy Fails to Meet Primary Endpoint in Early-Stage TNBC Christos Evangelou, MSc, PhD December 17, 2024

https://www.medscape.com/viewarticle/atezolizumab-plus-neoadjuvant-chemotherapy-fails-meet-2024a1000nb2

No hay comentarios:

Publicar un comentario